CLGN - コルプラント・ホ―ルディングス (CollPlant Holdings Ltd.) コルプラント・ホ―ルディングス

 CLGNのチャート


 CLGNの企業情報

symbol CLGN
会社名 CollPlant Holdings Ltd (コルプラント・ホ―ルディングス)
分野(sector) Health Care   ヘルスケア
産業(industry) Industrial Specialties  
業種    医療関連(Health Care)
概要 事業概要 --   コルプラント・ホ―ルディングスはイスラエルの再生医薬品メ―カ―。組織や器官の3Dバイオプリンティングに注力し、人体由来・天然性の材料を用いるオ―ソバイオロジクスや先進創傷ケア市場向けの組織修復用医薬品の開発・商業化に従事する。同社製品は遺伝子工学技術における独自の組み換え体ヒトコラ―ゲンに基づく。本社所在地はネスジオナ。   CollPlant Biotechnologies Ltd. is a regenerative medicine company, which engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. The company's products include VergenixSTR, VergenixFG, and CollPlant Surgical Matrix. The company was founded by Oded Shoseyov in June 2004 and is headquartered in Rehovot, Israel.
本社所在地 3 Sapir Street Weizmann Science Park Ness Ziona 74140 ISR
代表者氏名
代表者役職名
電話番号
設立年月日 2004年
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 29人
url www.collplant.com
nasdaq_url https://www.nasdaq.com/symbol/clgn
adr_tso 149041
EBITDA EBITDA ー
終値(lastsale) 5.01
時価総額(marketcap) 746695.41
時価総額 時価総額 ―
売上高 売上高 --
企業価値(EV) 企業価値(EV) ー
当期純利益 当期純利益 --
決算概要 決算概要 --

 CLGNのテクニカル分析


 CLGNのニュース

   Is CollPlant Holdings Ltd. Sponsored (CLGN) Outperforming Other Medical Stocks This Year?  2020/06/03 15:30:17 Zacks Investment Research
Is (CLGN) Outperforming Other Medical Stocks This Year?
   What Makes CollPlant Holdings Ltd. Sponsored ADR (CLGN) a New Strong Buy Stock  2020/06/02 16:00:11 Zacks Investment Research
CollPlant Holdings Ltd. Sponsored ADR (CLGN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
   Has CollPlant Holdings Ltd. Sponsored (CLGN) Outpaced Other Medical Stocks This Year?  2020/04/08 15:30:11 Zacks Investment Research
Is (CLGN) Outperforming Other Medical Stocks This Year?
   CollPlant Biotechnologies Reports Year End Financial Results for Fiscal Year 2019  2020/04/01 11:00:00 PR Newswire
REHOVOT, Israel, April 1, 2020 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetics medicine company, today announced financial results for the full year ended December 31, 2019 and provided an update on the Company's business developments. Certain metrics, including…
   CollPlant Launches New Corporate Website to Showcase Recent Developments in Core Business Segments  2020/02/04 12:00:00 PR Newswire
REHOVOT, Israel, Feb. 4, 2020 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company, today announced the launch of its updated corporate website. The new website has a clean uncluttered design, improved functionality and enhanced rich content focused on…
   Has CollPlant Holdings Ltd. Sponsored (CLGN) Outpaced Other Medical Stocks This Year?  2020/04/08 15:30:11 Zacks Investment Research
Is (CLGN) Outperforming Other Medical Stocks This Year?
   CollPlant Biotechnologies Reports Year End Financial Results for Fiscal Year 2019  2020/04/01 11:00:00 PR Newswire
REHOVOT, Israel, April 1, 2020 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetics medicine company, today announced financial results for the full year ended December 31, 2019 and provided an update on the Company's business developments. Certain metrics, including…
   CollPlant Launches New Corporate Website to Showcase Recent Developments in Core Business Segments  2020/02/04 12:00:00 PR Newswire
REHOVOT, Israel, Feb. 4, 2020 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company, today announced the launch of its updated corporate website. The new website has a clean uncluttered design, improved functionality and enhanced rich content focused on…
   CollPlant Partners in the Advanced Regenerative Manufacturing Institute  2020/01/06 12:00:00 PR Newswire
REHOVOT, Israel, Jan. 6, 2020 /PRNewswire/ -- CollPlant (NASDAQ:CLGN), a regenerative medicine company, today announced it is now part of a new public-private ManufacturingUSA initiative, the Advanced Regenerative Manufacturing Institute (ARMI). Headquartered in Manchester, New Hampshire,…
   CollPlant Publishes Letter to Shareholders  2019/12/19 12:00:00 PR Newswire
REHOVOT, Israel, Dec. 19, 2019 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative medicine company, today announced that Yehiel Tal, Chief Executive Officer of CollPlant Biotechnologies, has issued a Letter to Shareholders, the full text of which follows below. Dear Fellow…
   CollPlant Partners in the Advanced Regenerative Manufacturing Institute  2020/01/06 12:00:00 PR Newswire
REHOVOT, Israel, Jan. 6, 2020 /PRNewswire/ -- CollPlant (NASDAQ:CLGN), a regenerative medicine company, today announced it is now part of a new public-private ManufacturingUSA initiative, the Advanced Regenerative Manufacturing Institute (ARMI). Headquartered in Manchester, New Hampshire,…
   CollPlant Publishes Letter to Shareholders  2019/12/19 12:00:00 PR Newswire
REHOVOT, Israel, Dec. 19, 2019 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative medicine company, today announced that Yehiel Tal, Chief Executive Officer of CollPlant Biotechnologies, has issued a Letter to Shareholders, the full text of which follows below. Dear Fellow…
   CollPlant EPS in-line, beats on revenue  2019/05/30 11:32:56 Seeking Alpha
   Regenerative medicine firm CollPlant launches Israel R&D center  2019/05/22 12:40:49 Reuters
CollPlant, which makes products for tissue repair and organ manufacturing from its recombinant human collagen, has launched a new research and development center in Israel.
   Regenerative medicine firm CollPlant launches Israel R&D centre  2019/05/22 12:18:43 Reuters
CollPlant, which makes products for tissue repair and organ manufacturing from its recombinant human collagen, has launched a new research and development centre in Israel.

 関連キーワード  (― 米国株 コルプラント・ホ―ルディングス CLGN CollPlant Holdings Ltd.)

 twitter  (公式ツイッターやCEOツイッターなど)